Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Choosing a treatment should involve more than requesting the most popular injection
Your doctor can tell you how to lower the dose gradually and stop treatment over a period of days to weeks
Companies must also invest in consumer education to communicate the value of these products effectively
Co., Ltd., n=60) [Weight Loss/Efficacy] Trials: NCT07677891 | Mechanism: GLP-1/GLP-2 dual agonist CLARA Trial Phase 2 investigating the biological impact of GLP-1/GIP receptor agonists in patients with breast cancer (Universitaire Ziekenhuizen KU Leuven, n=168) [New Indications] Trials: NCT07676331 (CLARA) | Mechanism: Dual GLP-1/GIP agonist Semaglutide microarray patch (VX-201) Phase 1 comparing epi-intradermal delivery to standard subcutaneous injection in healthy overweight and obese participants (Terrestrial Bio, n=62) [Novel Delivery] Trials: NCT07673900 | Mechanism: GLP-1 receptor agonist This newsletter compiles publicly available information from press releases, news sources, and trial registries
Commonly used for weight loss, energy, pernicious anemia, schilling test and overall health.
A typical approach might involve adding your daily dose to a balanced breakfast containing whole grains and protein, or mixing it into a post-meal beverage
